Astellas gets Japanese approval for Evrenzo to treat anaemia of CKD in adult patients not on dialysis

This article was originally published here

In 2019, Astellas and FibroGen have also received Japanese approval for roxadustat for the treatment of adult patients with anaemia of CKD on dialysis. FibroGen now secures a

The post Astellas gets Japanese approval for Evrenzo to treat anaemia of CKD in adult patients not on dialysis appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply